Antitumor alkaloids for Cephalataxus harringtonia: structure and activity.
D000470:Alkaloids / Q000008:administration & dosage / Q000302:isolation & purification / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000302:isolation & purification*; D004149:Dioxoles / Q000627:therapeutic use; D004952:Esters / Q000302:isolation & purification / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D010936:Plant Extracts / Q000627:therapeutic use; D013057:Spectrum Analysis; D013329:Structure-Activity Relationship
D000470:Alkaloids; D000970:Antineoplastic Agents; D004149:Dioxoles; D004952:Esters; D010936:Plant Extracts